Global Active Biological Bone Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Latest Trends
Publisher : MRA | Format : PDF
Global Active Biological Bone Market Research Report 2024
Active biological bone is a new type of bone repair material with osteoconduction and osteoinduction, which is made by compounding bone repair material with recombinant human bone morphogenetic protein (rhBMP-2) with collagen-specific binding ability. It is mainly used to fill bone defects caused by trauma or surgery that do not affect the stability of bone structure.
According to MRA Research’s new survey, global Active Biological Bone market is projected to reach US$ million in 2033, increasing from US$ million in 2023, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Active Biological Bone market research.
At present, the commonly used clinical materials for orthopedic repair mainly include autologous bone, allogeneic bone, traditional artificial bone and bioactive bone. Compared with traditional repair materials, active bio-bone can be combined with bone repair materials through recombinant signal molecules that can specifically bind to collagen to achieve highly directional repair, and the clinical efficacy is not inferior to autologous bone. It will become the best treatment for bone defects at present. implant material.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Active Biological Bone market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Medtronic
Stryker
Yantai Zhenghai Bio-Tech
CoreBone
Hangzhou Jiuyuan Gene Engineering
Segment by Type
Infuse
OP-1
Hospital
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Active Biological Bone report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRA Research’s new survey, global Active Biological Bone market is projected to reach US$ million in 2033, increasing from US$ million in 2023, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Active Biological Bone market research.
At present, the commonly used clinical materials for orthopedic repair mainly include autologous bone, allogeneic bone, traditional artificial bone and bioactive bone. Compared with traditional repair materials, active bio-bone can be combined with bone repair materials through recombinant signal molecules that can specifically bind to collagen to achieve highly directional repair, and the clinical efficacy is not inferior to autologous bone. It will become the best treatment for bone defects at present. implant material.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Active Biological Bone market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Medtronic
Stryker
Yantai Zhenghai Bio-Tech
CoreBone
Hangzhou Jiuyuan Gene Engineering
Segment by Type
Infuse
OP-1
Segment by Application
Hospital
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Active Biological Bone report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source